These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in Heidenhain pouch dogs (author's transl)].
    Author: Ohtsuki H, Okabe S.
    Journal: Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):539-47. PubMed ID: 6120885.
    Abstract:
    The effects of ranitidine on gastric secretion stimulated with gastric secretagogues were studied in 6 Heidenhain pouch dogs (both male beagle and mongrel). Cimetidine was used as a reference drug. Either histamine 2HCl (40 micrograms/kg), pentagastrin (2 micrograms/kg) or carbachol (2 micrograms/kg) was given intramuscularly, every 15 min for 120 min. Gastric juice was collected at each 15 min interval and analyzed for volume, acidity and pepsin activity. Either ranitidine (0.3, 1 or 10 mg/kg) or cimetidine (1 or 10 mg/kg), packed in a gelatin capsule, was given orally 60 min before the initial injection of each stimulant. Both ranitidine and cimetidine dose-dependently inhibited histamine- and pentagastrin-stimulated gastric secretion (volume, acid and pepsin output). These agents also inhibited the carbachol-stimulated secretion, but the antisecretory effects were weak as compared with their effects on histamine- and pentagastrin-stimulated secretions. The antisecretory effect of ranitidine on each stimulant is roughly 2 to 17 times more potent than cimetidine on the basis of ED50 (anti-secretory dose which inhibits gastric secretion by 50%). The antisecretory effect of ranitidine (10 mg/kg) on pentagastrin-stimulated secretion was observed even 10 hr after its oral administration.
    [Abstract] [Full Text] [Related] [New Search]